Novo Nordisk AS (NVO) Stock Price, Quote, News & History

NVONYSE
$41.17
2.656.88%
At close: Apr 24, 5:00 PM EST
$41.39
0.220.53%
After Hours: Apr 24, 7:59 PM EST
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
119.10B
Investing Cash Flow (TTM)
-79.16B
Financing Cash Flow (TTM)
-28.41B
Free Cash Flow (TTM)
28.99B
Capital Expenditure (TTM)
-90.11B
Net Change in Cash (TTM)
11.54B

Analyst Trends and Forecast

0
0
0
0
Dec 25
1
Jan
1
Feb
1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$196.49B
PE Ratio (TTM)
10.65
PE Ratio (FWD)
11.38
PEG Ratio (TTM)
4.22
PS Ratio (TTM)
3.53
PB Ratio (TTM)
5.60
Earnings Yield % (TTM)
9.39%
Earnings Yield % (FWD)
8.79%
EV / EBITDA (TTM)
7.64
Price / EBITDA (TTM)
6.96
Price / Free Cash Flow (TTM)
37.62
Book Value / Share
$6.87

Company Debt

Total Debt
$122.39B
LT Debt
$111.71B
LT Debt Issuance (TTM)
$103.93B
LT Debt Repayment (TTM)
-$79.19B
Total Cash
$26.46B
Debt to Equity
0.67
Issuance of Debt (TTM)
$24.74B
Repayment of Debt (TTM)
-$79.19B

Key Statistics

Open
$40.06
Close
$41.17
Volume / Avg.
25.02M / 21.92M
Day Range
$39.89 - $41.23
52 Wk Range
35.12 - 81.44
Market Cap
$183.58B
P/E Ratio
10.65
Dividend Yield
4.68%
Exchange
NYSE
RSI
61
Short Interest
0.53%
Days to Cover
1.11

About

Sector
Health Care
Industry
Pharmaceuticals
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, inject...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Novo Nordisk (NVO) stock?

A

You can purchase shares of Novo Nordisk (NYSE:NVO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Novo Nordisk (NVO) competitors?

A

There are no as such competitors for Novo Nordisk.

Q

What is the forecast, or price target, for Novo Nordisk (NVO) stock?

A

Novo Nordisk has a consensus price target of $85.31.

Q

What is the current price for Novo Nordisk (NVO)?

A

The stock price for Novo Nordisk (NYSE: NVO) is $41.39 last updated April 24, 2026 at 7:59 PM EDT.

Q

Does Novo Nordisk (NVO) pay a dividend?

A

There are no upcoming dividends for Novo Nordisk.

Q

When is Novo Nordisk (NYSE:NVO) reporting earnings?

A

Novo Nordisk does not have any upcoming earnings scheduled.

Q

Is Novo Nordisk (NVO) going to split?

A

There is no upcoming split for Novo Nordisk.

Q

What sector and industry does Novo Nordisk (NVO) operate in?

A

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.